{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T02:52:58Z","timestamp":1761706378591},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13287-017-0723-y","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:00:53Z","timestamp":1513170053000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pentosan polysulfate binds to STRO-1+ mesenchymal progenitor cells, is internalized, and modifies gene expression: a novel approach of pre-programing stem cells for therapeutic application requiring their chondrogenesis"],"prefix":"10.1186","volume":"8","author":[{"given":"Jiehua","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Shimmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Paton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Goldschlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan","family":"Gronthos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"723_CR1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641\u201350.","journal-title":"J Orthop Res"},{"key":"723_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"723_CR3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","volume":"19","author":"P Bianco","year":"2001","unstructured":"Bianco P, Rimininucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology and potential applications. Stem Cells. 2001;19:180\u201392.","journal-title":"Stem Cells"},{"key":"723_CR4","doi-asserted-by":"crossref","unstructured":"Zannettino ACW, Paton S, Kortesidis A, Khor F, Itescu S, Gronthos S. Human Mulipotential Stromal Stem Cells are Derived from a Discrete Subpopulation of STRO-1bright\/CD34-\/CD45-\/Glycophorin-A- Bone Marrow Cells. Haematologica. 2007;92:1707\u20138.","DOI":"10.3324\/haematol.11691"},{"key":"723_CR5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.22203\/eCM.v030a02","volume":"30","author":"X Tang","year":"2015","unstructured":"Tang X, Fan L, Pei M, Zeng L, Ge Z. Evolving concepts of chondrogenic differentiation: history, state-of-the-art and future perspectives. Eur Cell Mater. 2015;30:12\u201327.","journal-title":"Eur Cell Mater"},{"key":"723_CR6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/cdd.2013.158","volume":"21","author":"S Ma","year":"2014","unstructured":"Ma S, Xie W, Yuan B, Shi Y, Wang Y. Immunology of mesenchymal stem cells. Cell Death Differ. 2014;21:216\u201325.","journal-title":"Cell Death Differ"},{"key":"723_CR7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"A Caplan","year":"2009","unstructured":"Caplan A. Why are MSCs therapeutic? New data: new insight. J Pathol. 2009;217:318\u201324.","journal-title":"J Pathol"},{"key":"723_CR8","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney DG, Prockop DJ. Concise review: mesenchymal stem\/multipotent stromal cells: the state of trans differentiation and modes of tissue repair\u2014current views. Stem Cells. 2007;25:2896\u2013902.","journal-title":"Stem Cells"},{"key":"723_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","volume":"8","author":"A Becker De","year":"2016","unstructured":"De Becker A, Riet IV. Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy. World J Stem Cells. 2016;8:73\u201387.","journal-title":"World J Stem Cells"},{"key":"723_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/ar614","volume":"5","author":"RS Tuan","year":"2003","unstructured":"Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell based tissue engineering. Arthritis Res Ther. 2003;5:32\u201345.","journal-title":"Arthritis Res Ther"},{"key":"723_CR11","first-page":"233","volume":"10","author":"FH Chen","year":"2008","unstructured":"Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:233\u201345.","journal-title":"Arthritis Res Ther"},{"key":"723_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.berh.2008.01.005","volume":"22","author":"C Jorgensen","year":"2008","unstructured":"Jorgensen C, Djouad F, Bouffi C, Mrugala D, et al. Multipotent mesenchymal stromal cells in articular diseases. Best Pract Res Clin Rheumatol. 2008;22:269\u201384.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"723_CR13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrrheum.2013.109","volume":"9","author":"F Barry","year":"2013","unstructured":"Barry F, Murphy M. Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol. 2013;9:584\u201394.","journal-title":"Nat Rev Rheumatol"},{"key":"723_CR14","doi-asserted-by":"publisher","first-page":"3908389","DOI":"10.1155\/2016\/3908389","volume":"2016","author":"J Zeckser","year":"2016","unstructured":"Zeckser J, Wolff M, Tucker J, Goodwin J. Multipotent mesenchymal stem cell treatment for discogenic low back pain and disc degeneration. Strm Cells Int. 2016;2016:3908389. doi:\n10.1155\/2016\/3908389\n\n.","journal-title":"Strm Cells Int"},{"key":"723_CR15","doi-asserted-by":"publisher","first-page":"946031","DOI":"10.1155\/2015\/946031","volume":"2015","author":"D Oehme","year":"2015","unstructured":"Oehme D, Goldschlager T, Ghosh P, Rosenfeld JV, Jenkin G. Cell-based therapies used to treat lumbar degenerative disc disease: a systematic review of animal studies and human clinical trials. Stem Cell Int. 2015;2015:946031. doi:\n10.1155\/2015\/946031\n\n.","journal-title":"Stem Cell Int"},{"key":"723_CR16","doi-asserted-by":"publisher","unstructured":"Richardson SM, Kalamegam G, Pushparaj PN, Matta C, Memic A, et al. Mesenchymal stem cells in regenerative medicine: focus on articular cartilage and intervertebral disc degeneration. Methods. 2016; doi:\n10.1016\/j.ymeth.2015.09.015\n\n.","DOI":"10.1016\/j.ymeth.2015.09.015"},{"key":"723_CR17","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1002\/art.11365","volume":"48","author":"JM Murphy","year":"2003","unstructured":"Murphy JM, Fink DJ, Hunziker EB, Barry FB. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum. 2003;48:3464\u201374.","journal-title":"Arthritis Rheum"},{"key":"723_CR18","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1634\/stemcells.2006-0311","volume":"25","author":"KBL Lee","year":"2007","unstructured":"Lee KBL, Hui JHP, Song IC, Ardany L, Lee EH. Injectable mesenchymal stem cell therapy for large cartilage defects\u2014a porcine model. Stem Cells. 2007;25:2964\u201371.","journal-title":"Stem Cells"},{"key":"723_CR19","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1002\/art.22136","volume":"54","author":"K Pelttari","year":"2006","unstructured":"Pelttari K, Winter A, Steck E, Goetzke K, Hennig T, et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 2006;54:3254\u201366.","journal-title":"Arthritis Rheum"},{"key":"723_CR20","doi-asserted-by":"publisher","unstructured":"Ahmed N, Stanford WI, Kandel RA. Mesenchymal and progenitor cells for cartilage repair. Skeletal Radiology. 2007: doi \n10.1007\/s00256-007-0333-3\n\n.","DOI":"10.1007\/s00256-007-0333-3"},{"issue":"1","key":"723_CR21","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2935","volume":"12","author":"P Ghosh","year":"2010","unstructured":"Ghosh P, Wu J, Shimmon S, Zannettino AC, Gronthos S, Itescu S. Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells. Arthritis Res Ther. 2010;12(1):R28.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"723_CR22","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2010.3.FOCUS1050","volume":"28","author":"T Goldschlager","year":"2010","unstructured":"Goldschlager T, Ghosh P, Zannettino A, Gronthos S, Rosenfeld J, Itescu S, et al. Cervical motion preservation using mesenchymal progenitor cells and a novel chondrogenic agent, pentosan polysulfate\u2014a preliminary study in an ovine model. Neurosurg Focus. 2010;28(6):E4.","journal-title":"Neurosurg Focus"},{"key":"723_CR23","first-page":"1","volume":"22","author":"D Oehme","year":"2016","unstructured":"Oehme D, Ghosh P, Goldschlager T, et al. Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate. J Neurosurg Spine. 2016;22:1\u201312.","journal-title":"J Neurosurg Spine"},{"issue":"6","key":"723_CR24","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3171\/2014.2.SPINE13760","volume":"20","author":"D Oehme","year":"2014","unstructured":"Oehme D, Ghosh P, Shimmon S, et al. Mesenchymal progenitor cells combined with pentosan polysulfate mediating disc regeneration at the time of microdiscectomy: a preliminary study in an ovine model. J Neurosurg Spine. 2014;20(6):657\u201369.","journal-title":"J Neurosurg Spine"},{"key":"723_CR25","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1242\/jcs.00369","volume":"116","author":"S Gronthos","year":"2003","unstructured":"Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003;116:1827\u201335.","journal-title":"J Cell Sci"},{"issue":"2","key":"723_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-4165(86)90306-5","volume":"883","author":"RW Farndale","year":"1986","unstructured":"Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986;883(2):173\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"723_CR27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0003-2697(88)90532-5","volume":"174","author":"YJ Kim","year":"1988","unstructured":"Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluorometric assay for DNA in cartilage explants using Hoechst 33258. Anal Biochem. 1988;174:168\u201376.","journal-title":"Anal Biochem"},{"key":"723_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.1041240104","volume":"124","author":"JJ Castellot","year":"1985","unstructured":"Castellot JJ, Wong K, Herman B, Hoover RL, Albertini DF, et al. Binding and internalization of heparin by vascular smooth muscle cells. J Cellular Physiol. 1985;124:13\u201320.","journal-title":"J Cellular Physiol"},{"key":"723_CR29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0702559","volume":"127","author":"MK Patel","year":"1999","unstructured":"Patel MK, Refson JS, Schachter M, Hughes AD. Characterization of [3H]-heparin binding in human smooth muscle cells and its relationship to the inhibition of DNA synthesis. Br J Pharmacol. 1999;127:361\u20138.","journal-title":"Br J Pharmacol"},{"key":"723_CR30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-9-29","volume":"9","author":"CA Herbert","year":"2011","unstructured":"Herbert CA, Kwa MSG, Hermsen HPH. Risk factors in the development of stem cell therapy. J Transl Med. 2011;9:29.","journal-title":"J Transl Med"},{"issue":"3","key":"723_CR31","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8","volume":"75","author":"DG Phinney","year":"1999","unstructured":"Phinney DG, Kopen G, Righter W, Webster S, Tremain N, Prockop DJ. Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem. 1999;75(3):424\u201336.","journal-title":"J Cell Biochem"},{"key":"723_CR32","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3109\/14653240902974032","volume":"11","author":"KA Lee","year":"2009","unstructured":"Lee KA, Shim W, Paik MJ, Lee SC, Shin JY, Ahn YH, et al. Analysis of changes in the viability and gene expression profiles of human mesenchymal stromal cells over time. Cytotherapy. 2009;11:688\u201397.","journal-title":"Cytotherapy"},{"key":"723_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41598-017-01315-0","volume":"7","author":"TH Shin","year":"2017","unstructured":"Shin TH, Lee S, Choi KR, Lee DY, Kim Y, Jeong M, et al. Quality and freshness of human bone marrow-derived mesenchymal stem cells decreases over time after trypsininization and storage in phosphate buffered saline. Nat Sci Rep. 2017;7:1106. doi:\n10.1038\/s41598-017-01315-0\n\n.","journal-title":"Nat Sci Rep"},{"key":"723_CR34","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/art.24786","volume":"60","author":"HJ Lee","year":"2009","unstructured":"Lee HJ, Choi BH, Min B-H, Park SR. Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and de-differentiation process in vitro. Arthritis Rheum. 2009;60:2325\u201332.","journal-title":"Arthritis Rheum"},{"key":"723_CR35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00418-008-0379-x","volume":"129","author":"A Schrage","year":"2006","unstructured":"Schrage A, Loddenkemper C, Erben U, Lauer U, Hausdorf G, Jungblut PR, et al. Murine CD146 is widely expressed on endothelial cells and is recognized by the monoclonal antibody ME-9\u00a0F1. HistchemCell Biol. 2006;129:441\u201351.","journal-title":"HistchemCell Biol"},{"key":"723_CR36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.stem.2008.07.003","volume":"3","author":"M Crisan","year":"2008","unstructured":"Crisan M, Yap S, Castella L, Chen C-W, Corselli M, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301\u201313.","journal-title":"Cell Stem Cell"},{"key":"723_CR37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/cr.2015.15","volume":"25","author":"T Tu","year":"2015","unstructured":"Tu T, Zhang C, Yan H, Luo Y, Kong R, Wen P, et al. CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development. Cell Res. 2015;25:275\u201387.","journal-title":"Cell Res"},{"key":"723_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13287-015-0266-z","volume":"7","author":"L Harkness","year":"2016","unstructured":"Harkness L, Zaher W, Ditzel W, Isa A, Kassem M. CD146\/MCAM defines functionality of human bone marrow stromal stem cell populations. Stem Cell Res Ther. 2016;7:4. doi:\n10.1186\/s13287-015-0266-z\n\n.","journal-title":"Stem Cell Res Ther"},{"key":"723_CR39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/ar630","volume":"5","author":"H Nagase","year":"2003","unstructured":"Nagase H, Kashiwagi M. Aggrecanases and cartilage matrix degradation. Arthritis Res Ther. 2003;5:94\u2013103.","journal-title":"Arthritis Res Ther"},{"key":"723_CR40","doi-asserted-by":"crossref","first-page":"53331","DOI":"10.1074\/jbc.M409622200","volume":"279","author":"RJ Wenstrup","year":"2004","unstructured":"Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I, Birk DE. Type V collagen controls the initiation of collagen fibre assembly. J Biological Chem. 2004;279:53331\u20137.","journal-title":"J Biological Chem"},{"key":"723_CR41","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jcb.23455","volume":"4","author":"HH Smith","year":"2012","unstructured":"Smith HH, Calderon R, Song Y, Tuan RS, Chen FH. Cartilage oligomeric matrix protein enhances matrix assembly during chondrogenesis of human mesenchymal stem cells. J Cell Biochem. 2012;4:1245\u201352.","journal-title":"J Cell Biochem"},{"key":"723_CR42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1196\/annals.1346.010","volume":"1068","author":"M Pacifici","year":"2006","unstructured":"Pacifici M, Koyama E, Shibukawa Y, Tamamura Y, et al. Cellular and molecular mechanisms of synovial joint and articular cartilage formation. Ann NY Acad Sci. 2006;1068:74\u201386.","journal-title":"Ann NY Acad Sci"},{"key":"723_CR43","first-page":"1549","volume":"5","author":"SJ Busch","year":"1990","unstructured":"Busch SJ, Sassone-Corsi P. Fos, Jun, and CREB basic domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor. Oncogene. 1990;5:1549\u201356.","journal-title":"Oncogene"},{"key":"723_CR44","first-page":"389","volume":"2","author":"EF Wagner","year":"2002","unstructured":"Wagner EF, Karsenty G. Genetic control of skeletal development. Curr Opin Gene Dev. 2002;2:389\u2013406.","journal-title":"Curr Opin Gene Dev"},{"issue":"1","key":"723_CR45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1083\/jcb.116.1.31","volume":"116","author":"SJ Busch","year":"1992","unstructured":"Busch SJ, Martin GA, Barnhart RL, Mano M, Cardin AD, Jackson RL. Trans-repressor activity of nuclear glycosaminglycans on Fos and Jun\/AP-1 oncoprotein-mediated transcription. J Cell Biology. 1992;116(1):31\u20132.","journal-title":"J Cell Biology"},{"key":"723_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0014-5793(98)00073-8","volume":"423","author":"G Pintus","year":"1996","unstructured":"Pintus G, Tadolini B, Maioi M, Posadino AM, Bennardini F, et al. Heparin inhibits phorbol ester-induced ornithine decarboxylase gene expression in endothelial cells. FEBS Lett. 1996;423:98\u2013104.","journal-title":"FEBS Lett"},{"key":"723_CR47","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/jcp.24677","volume":"12","author":"AC Gilotti","year":"2014","unstructured":"Gilotti AC, Nimlamool W, Pugh R, Slee JB, Barthol TC, Miller EA, et al. Heparin responses in vascular smooth muscle cells involves cGMP dependent protein kinase (PKG). J Cell Physiol. 2014;12:2142\u201352.","journal-title":"J Cell Physiol"},{"key":"723_CR48","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1074\/jbc.M115.681288","volume":"291","author":"SL Farwell","year":"2016","unstructured":"Farwell SL, Kanyl D, Hamel M, Slee JG, Miller EA, Cipolle MD, et al. Heparin decreases in tumor necrosis factor a (TNF-alpha)-induced endothelial stress response requires transmembrane protein 184A and induction of dual specificity phosphatase-1. J Biol Chem. 2016;291:5342\u201354.","journal-title":"J Biol Chem"},{"key":"723_CR49","doi-asserted-by":"crossref","first-page":"13409","DOI":"10.1073\/pnas.0806136105","volume":"105","author":"MK Furue","year":"2008","unstructured":"Furue MK, Na J, Jackson JP, Okamoto T, Jones M, Baker D, Hata R, Moore HD, Sato JD, Andrews PW. Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc Natl Acad Sci. 2008;105:13409\u201314.","journal-title":"Proc Natl Acad Sci"},{"key":"723_CR50","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1074\/jbc.M705621200","volume":"283","author":"N Sasaki","year":"2008","unstructured":"Sasaki N, Okishio K, Ui-Tei K, Saigo K, Kinoshita-Toyoda A, Toyoda H, Nishimura S, et al. Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. J Biol Chem. 2008;283:3594\u2013606.","journal-title":"J Biol Chem"},{"key":"723_CR51","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1089\/ten.tea.2008.0405","volume":"15","author":"BE Uygun","year":"2009","unstructured":"Uygun BE, Stojsih SE, Matthew HW. Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells. Tissue Eng Part A. 2009;15:3499\u2013512.","journal-title":"Tissue Eng Part A"},{"key":"723_CR52","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.gene.2015.10.039","volume":"576","author":"L Ling","year":"2016","unstructured":"Ling L, Camilleri ET, Helledie T, Samsonra RM, Titmarsh DM, et al. Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells. Gene. 2016;576:292\u2013303.","journal-title":"Gene"},{"key":"723_CR53","first-page":"1541","volume":"9","author":"O Jacbsson","year":"1986","unstructured":"Jacbsson O, Kuver T, Granath K. Characterization of xylan sulphate by size exclusion chromatography. J Liquid Chromatography. 1986;9:1541\u201361.","journal-title":"J Liquid Chromatography"},{"key":"723_CR54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","volume":"47","author":"I Capila","year":"2002","unstructured":"Capila I, Linhardt RJ. Heparin\u2013protein interactions. Angew Chem Int Ed. 2002;47:390\u2013412.","journal-title":"Angew Chem Int Ed"},{"key":"723_CR55","first-page":"363","volume-title":"Second-line agents in the treatment of rheumatic diseases","author":"P Ghosh","year":"1992","unstructured":"Ghosh P, Smith M, Wells C. Second line agents in osteoarthritis. In: Dixon JS, Furst DE, editors. Second-line agents in the treatment of rheumatic diseases. New York: Dekker; 1992. p. 363\u2013427."},{"issue":"Suppl 1","key":"723_CR56","first-page":"S21","volume":"4","author":"JMH Teichman","year":"2002","unstructured":"Teichman JMH. The role of pentosan polysulfate in treatment approaches for interstitial cystitis. Urology. 2002;4 Suppl 1:S21\u20137.","journal-title":"Urology"},{"key":"723_CR57","first-page":"1444","volume":"25","author":"W Shlotmann","year":"1969","unstructured":"Shlotmann W. Uber den Heilerfolg der Tendovaginitis fibrinosa unter SP-54\u2014Applikation. Med Welt H. 1969;25:1444\u20139.","journal-title":"Med Welt H"},{"issue":"4","key":"723_CR58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0049-0172(99)80021-3","volume":"28","author":"P Ghosh","year":"1999","unstructured":"Ghosh P. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Seminars Arthritis Rheum. 1999;28(4):211\u201367.","journal-title":"Seminars Arthritis Rheum"},{"key":"723_CR59","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.curtheres.2005.12.012","volume":"66","author":"P Ghosh","year":"2005","unstructured":"Ghosh P, Edelman J, March L, Smith M. Effects of pentosan polysulfate in osteoarthritis of the knee: a randomized, double blind, placebo-controlled pilot study. Curr Ther Res. 2005;66:552\u201371.","journal-title":"Curr Ther Res"},{"key":"723_CR60","doi-asserted-by":"crossref","unstructured":"Kumagai K, Shurabe K, Miyata N, Murata M, Yamauchi A, Kataoka Y. et al. Sodium pentosane polysulfate resulted in cartilage improvement in knee osteoarthritis\u2014an open clinical trial. BMC Clinical Pharmacol. 2010;10:7. \nhttp:\/\/www.biomedcentral.com\/1472-6904\/10\/7\n\n.","DOI":"10.1186\/1472-6904-10-7"},{"key":"723_CR61","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1128\/JVI.00224-15","volume":"89","author":"LJ Herrero","year":"2015","unstructured":"Herrero LJ, Foo S-S, Sheng K, Chen WC, Forwood MS, et al. Pentosan polysulfate: a novel glycosaminoglycan-like molecule for effective treatment of alphavirus-induced cartilage destruction and inflammatory disease. J Virol. 2015;89:8063\u201376.","journal-title":"J Virol"},{"key":"723_CR62","doi-asserted-by":"crossref","unstructured":"Daly CD, Ghosh P, Zannettino AC, Badal T, Shimmon R, Jenkin G, Jain K, Oehme D, et al. Mesenchymal progenitor cells primed with pentosan polysulfate promote lumbar intervertebral disc regeneration in an ovine model of microdiscectomy. Spine J. 2017(in press).","DOI":"10.1016\/j.spinee.2017.10.008"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-017-0723-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T13:01:14Z","timestamp":1513170074000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-017-0723-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["723"],"URL":"https:\/\/doi.org\/10.1186\/s13287-017-0723-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"278"}}